Many advisors help interpret the science.
Few help deliver the programme.
Linchpin is an independent, strategic scientific and operational partner, combining senior scientific judgement with hands-on delivery to guide programmes from concept through preclinical development and into early clinical execution.
The gap Linchpin solves
Many organisations rely on separate layers of scientific advisors, consultants, CROs and service providers. This often leads to disconnected decision-making, gaps between strategy and execution, lack of accountability for delivery and slower, less capital-efficient progress.
Insight without execution does not move programmes forward.
The Linchpin model
Independent scientific evaluation of your programme
Ensuring clarity on where the programme stands and what needs to be addressed.
Development of a clear, integrated development pathway
Creating a development plan that is credible, aligned, and executable.
Embedded execution to advance the programme
Bringing teams, expertise and partners together to ensure strategy is translated into real programme delivery.
A clear and navigable path from insight to execution.
In practice
Linchpin operates as part of your team, not as an external advisory layer.
Early-stage drug development requires alignment across multiple scientific disciplines, external partners, and CRO relationships, all moving at different speeds, with different priorities, and often without a clear centre of gravity.
Linchpin acts as that centre. We integrate strategy and execution into a single coherent pathway, coordinating the expertise, managing the relationships, and maintaining accountability for delivery from concept to clinic.
SCIENTIFIC
EXPERTISE
CRO
PARTNERS
PROGRAMME
DELIVERY
DEVELOPMENT
STRATEGY
INVESTOR
READINESS
REGULATORY
PATHWAY
When Linchpin is engaged
Build an evidence-led development plan, identify capability gaps and align the programme with its first financing milestones.
Coordinate specialist expertise, CRO partners and development activities as the programme moves towards IND-enabling work.
Stress-test the science, clarify key risks and prepare a credible, executable development story for investor scrutiny.
Translate the investment plan into coordinated teams, accountable partners and delivery against programme milestones.
Identify the causes of delay, reset priorities and align the team around a practical path back to delivery.
Whether you are developing a programme or evaluating an opportunity, Linchpin provides the scientific and operational capability to help you navigate early-stage drug development and move forward with clarity.